mdxhealth
Suzanne Jansen is a Molecular Diagnostic Specialist at MDxHealth, where since February 2020, the focus has been on providing non-invasive molecular diagnostics to enhance prostate cancer patient stratification and early detection. Prior to this role, Suzanne Jansen had an extensive career at GlaxoSmithKline Pharmaceuticals, serving as a Senior Executive Pharmaceutical Sales Specialist and Senior Healthcare Consultant from August 1996 to January 2019, contributing to consumer healthcare initiatives. Suzanne Jansen holds a Bachelor of Arts in Psychology from California State University, Fullerton.
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.